Vučinić, D., Skočilić, I., Golčić, M., Dobrila Dintinjana, R., Kolak, M., Jerković, I. ... Mikolašević, I. (2024). Effectiveness and Safety of Immune Checkpoint Inhibitors in Older Cancer Patients. Journal of Personalized Medicine, 14. (3). doi: 10.3390/jpm14030278
Vučinić, Damir, et al. "Effectiveness and Safety of Immune Checkpoint Inhibitors in Older Cancer Patients." Journal of Personalized Medicine, vol. 14, br. 3, 2024. https://doi.org/10.3390/jpm14030278
Vučinić, Damir, Iva Skočilić, Marin Golčić, Renata Dobrila Dintinjana, Maja Kolak, Ivona Jerković, Eleonora Cini Tesar, et al. "Effectiveness and Safety of Immune Checkpoint Inhibitors in Older Cancer Patients." Journal of Personalized Medicine 14, br. 3 (2024). https://doi.org/10.3390/jpm14030278
Vučinić, D., et al. (2024) 'Effectiveness and Safety of Immune Checkpoint Inhibitors in Older Cancer Patients', Journal of Personalized Medicine, 14(3). doi: 10.3390/jpm14030278
Vučinić D, Skočilić I, Golčić M, Dobrila Dintinjana R, Kolak M, Jerković I, i sur.. Effectiveness and Safety of Immune Checkpoint Inhibitors in Older Cancer Patients. Journal of Personalized Medicine [Internet]. 01.03.2024. [pristupljeno 19.08.2024.];14(3). doi: 10.3390/jpm14030278
D. Vučinić, et al., "Effectiveness and Safety of Immune Checkpoint Inhibitors in Older Cancer Patients", Journal of Personalized Medicine, vol. 14, br. 3, Ožujak 2024. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:957807. [Citirano: 19.08.2024.]